DOCSLIB.ORG

Partners FORUM 2020 PROGRAM (Boston) 200508 1332 FREV2

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Partners FORUM 2020 PROGRAM (Boston) 200508 1332 FREV2 COVID-19, AI and the Future of Medicine Front Line Innovations and Insights MAY 11, 2020 VIRTUAL GATHERING worldmedicalinnovation.org 2 3 CONTENTS 7 Welcome 11 Steering Committee 13 Sponsors 14 Imagining Health Care in 2030 15 Lynn Bry, MD, PhD 15 Alistair Erskine, MD 16 Keith Flaherty, MD 17 Daphne Haas-Kogan, MD 17 Jayashree Kalpathy-Cramer, PhD 18 Elizabeth Karlson, MD 19 Bharti Khurana, MD 19 Adam Landman, MD 20 Thomas McCoy, MD 20 Patricia Musolino, MD, PhD 21 Rochelle Walensky, MD 21 Bradley Welling, MD, PhD 22 Mass General Brigham Innovation 24 Agenda 30 Innovation Growth Board 32 Commercialization Council 41 Planning Committee 43 2021 World Medical Innovation Forum + worldmedicalinnovation.org Partners HealthCare is now Mass General Brigham WEB BLOG worldmedicalinnovation.org innovationblog.partners.org LINKEDIN TWITTER Partners HealthCare Innovation @PHSInnovation YOUTUBE HASHTAG World Medical Innovation Forum #WMIF2020 SPEAKER AFFILIATIONS BH | Brigham and Women's Hospital; MGH | Massachusetts General Hospital; HMS | Harvard Medical School; MEE | Mass. Eye and Ear; NWH | Newton-Wellesley Hospital TogetherTogether we are strong. Bayer is contributing to the global fight against the coronavirus through our products and expertise in health and nutrition. bayer.com/corona DRUCK_BAG_Anz_CoronaStrong_17x11Zoll_cmyk_mh04.indd Alle Seiten 27.04.20 09:53 Together we are strong. Bayer is contributing to the global fight against the coronavirus through our products and expertise in health and nutrition. bayer.com/corona DRUCK_BAG_Anz_CoronaStrong_17x11Zoll_cmyk_mh04.indd Alle Seiten 27.04.20 09:53 6 7 WELCOME This year we gather for the sixth annual World Medical Thank you for joining us. This year’s event will feature in- Innovation Forum in the extraordinary environment of depth engagement among expert panelists. Our enduring a world-wide pandemic that has altered medicine, the goal remains to provide an environment where principals delivery of care to patients, and the way we live. This virtual can directly share their insights and priorities. While the meeting will explore the technologies driving the response Forum’s speakers have been managing their organizations' to the coronavirus, how medicine is being reinvented real COVID-19 response they have also been reflecting on how time and how the urgency of today will take root in the care will be improved by the tools, insights and resolve future. In 18 virtually broadcast sessions, Mass General gained in fighting this pandemic. Brigham’s Harvard faculty, industry experts and leading The Forum is brought to you by Innovation, the global investors will jointly reflect on the technologies and business development arm of Mass General Brigham. Its challenges defining this historic era in health care. mission is the commercial application of the breakthroughs The World Medical Innovation Forum was established and unique capabilities of the system’s 6200 Harvard faculty to reaffirm the importance of collaborative innovation— —bringing benefits to patients worldwide and generating academia, industry and government working together to new resources to further the nation's largest academic create solutions to medicine’s great challenges. Our goal is research enterprise. Our work continues as we help to to provide actionable insights for Forum participants. We collaboratively shape fundamentally transformed care. are grateful to the 60 senior executives, investors, Harvard We express our deep appreciation to the many individuals clinicians and investigators who will share their insights as who made this Forum possible and are particularly grateful speakers. to our speakers for sharing their passion, expertise We welcome thousands of audience participants from and unique perspectives. Generous support by our dozens of countries and nearly every state. I thank our leading sponsors – Bayer, GE Healthcare, Biogen, Boston many sponsors representing some of the most innovative Scientific, Fujifilm, InterSystems, One Medical and Siemens companies in health care and the Steering Committee Healthineers – underpins today’s event. and Planning Team for their outstanding contributions. I Many thanks to the Steering Committee members whose recognize our Co-chairs Gregg Meyer, MD, Chief Clinical insights made the Forum possible and the Planning Team’s Officer, and Ravi Thadhani, MD, Chief Academic Officer, as dedicated work. well as Chris Coburn, Chief Innovation Officer, for their leadership. We hope that many of you will join us next year Enjoy the day and we look forward to seeing you in person in-person on May 10-12, 2021 when we reconvene. May 10-12, 2021 in Boston! Anne Klibanski, MD Gregg Meyer, MD President and CEO, Mass General Brigham; Chief Clinical Officer, Mass General Brigham; Laurie Carrol Guthart Professor of Medicine, Interim President, NWH; Professor of Medicine, HMS HMS (World Forum Co-Chair) Ravi Thadhani, MD Chief Academic Officer, Mass General Brigham; In addition to our dialogue today, we want Professor, HMS (World Forum Co-Chair) to share forecasts made by a number of our leading Harvard faculty on technologies that will characterize medicine in 2030. Christopher Coburn Please see page 15. Chief Innovation Officer, Mass General Brigham As these past weeks and months prove, THE FUTURE OF MEDICINE THANK YOU has – and always will be – people. Thank you to the hospital staffs, doctors, nurses, first responders and the entire healthcare community for showing the world how to bravely elevate patient care. gehealthcare.com As these past weeks and months prove, THE FUTURE OF MEDICINE THANK YOU has – and always will be – people. Thank you to the hospital staffs, doctors, nurses, first responders and the entire healthcare community for showing the world how to bravely elevate patient care. gehealthcare.com 10 11 Many thanks to the members of STEERING the Steering Committee for their leadership in shaping the Forum agenda, identifying speakers and COMMITTEE securing sponsors. Gregg Meyer, MD Ravi Thadhani, MD Chief Clinical Offi cer, Mass General Chief Academic Offi cer, Mass General Brigham; Interim President, NWH; Brigham; Professor, HMS (World Forum Professor of Medicine, HMS (World Co-Chair) Forum Co-Chair) Katherine Andriole, PhD Jeffrey Golden, MD John Miller, MD Director of Research Strategy Chair, Department of Pathology, Director, Retinal Imaging, and Operations, MGH & BH BH; Ramzi S. Cotran Professor of MEE; Assistant Professor, CCDS; Associate Professor, Pathology, HMS Ophthalmology, HMS Radiology, HMS Adele Gulfo Shawn Murphy, Samuel Aronson Chief of Commercial MD, PhD Executive Director, IT, Development, Roivant Sciences Chief Research Information Personalized Medicine, Mass Offi cer, Mass General Brigham; General Brigham Daphne Professor of Neurology, HMS Haas-Kogan, MD Dave Barrett Chair, Department of Radiation James Noga Managing Partner, VP and Chief Information Offi cer, Polaris Partners Oncology, BH; Professor of Radiation Oncology, HMS Mass General Brigham Giles Boland, MD Adam Koppel, MD, PhD Sunil Puria, PhD Chair, Department of Radiology, Managing Director, Bain Capital Associate Director of Eaton- BH; Philip H. Cook Professor of Life Sciences Fund Peabody Laboratories, Radiology, HMS MEE; Associate Professor of Otolaryngology-Head and Neck James Brink, MD Adam Landman, MD Surgery, HMS Radiologist-in-Chief, MGH; VP, Chief Information and Digital Innovation Offi cer, BH; Associate Juan M. Taveras Professor of Chandra Radiology, HMS Professor of Emergency Medicine, HMS Ramanathan, PhD Global Head, Pharma R&D Open Keith Dreyer, DO, PhD Innovation, Bayer Chief Data Science Offi cer, Mass David Louis, MD Pathologist-in-Chief, MGH; General Brigham; Vice Chairman, Sue Siegel Radiology, MGH; Associate Benjamin Castleman Board Member, Illumina, the Professor, Radiology, HMS Professor of Pathology, HMS Kaiser Family Foundation, and Align Technologies Alistair Erskine, MD Barbara Lubash Principal, Atlantic Chief Digital Health Offi cer, Mass Krishna Yeshwant, MD General Brigham Pacifi c Advisors Partner, Google Ventures; Instructor in Medicine, BH Jean-François Calum MacRae, MD, PhD Vice Chair, Scientifi c Innovation, Formela, MD CEO, One Brave Idea, BH; Partner, Atlas Venture Associate Professor of Medicine, HMS AFFILIATIONS BH | Brigham and Women's Hospital; MGH | Massachusetts General Hospital; HMS | Harvard Medical School; MEE | Mass. Eye and Ear 12 13 SPONSORS The 2020 Virtual World Medical Innovation Forum was made possible through the sponsorship of some of health care’s most important companies. STAKEHOLDER Bayer Leverkusen, Germany Bayer is a global enterprise with core competencies in the Life Science fi elds of health care and agriculture. Its products and services are designed to benefi t people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fi scal 2016, the Group employed around 115,200 people and had sales of EUR 46.8 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.7 billion. These fi gures include those for the high-tech polymers business, which was fl oated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.us. www.bayer.com GE Healthcare Chicago, IL Harnessing data and analytics across hardware, software and biotech, GE Healthcare
Load more

Recommended publications
  • Telemedicine for Treating Mental Health and Substance Use Disorders: Reflections Since the Pandemic
    www.nature.com/npp COMMENT Telemedicine for treating mental health and substance use disorders: reflections since the pandemic Neuropsychopharmacology (2021) 46:1068–1070; https://doi.org/10.1038/s41386-021-00960-4 INTRODUCTION telemedicine deployment in MH/SUD care are an important Since the United States COVID-19 pandemic emergency began, observation. This is because an often stated policy goal of telemedicine use has accelerated [1]. Prior to the pandemic, mental telemedicine is to improve access to care, particularly for patients health and/or substance use disorder (MH/SUD) care delivered by who lack geographic access to clinicians qualified to treat their telemedicine had been increasing but infrequently used—in fewer illness—for example, rural patients [12, 13]. Furthermore, MH/SUDs than 1% of visits [2, 3]. In contrast, in early October 2020, 41% of are considered to be particularly amenable to care via telemedi- MH/SUD visits were conducted via telemedicine [4]. The rapid cine, relative to other health care conditions; for example, earlier increase in telemedicine during the pandemic was enabled by research on the diffusion of telemedicine in Medicare found that sweeping temporary changes in federal and state regulations and nearly 80% of telemedicine visits were for mental health conditions health plan reimbursement policies that reduced longstanding [14]. However, there are some patients for whom the use of barriers. These changes included federal relaxation of HIPAA telemedicine, particularly video visits, poses significant barriers. compliance for telemedicine, removal of the requirement for an The “digital divide” affects many patients who are in groups that initial in-person appointment to prescribe buprenorphine (prohib- are already underserved—such as racial or ethnic minorities, those 1234567890();,: ited under the Ryan Haight Act), Medicare coverage for audio- in poverty, and the elderly [15–17].
    [Show full text]
  • Brigham and Women's Hospital
    PARTNERS HEALTHCARE SYSTEM, INC. BRIGHAM AND WOMEN’S HOSPITAL FAULKNER HOSPITAL MASSACHUSETTS GENERAL HOSPITAL MCLEAN HOSPITAL NORTH SHORE MEDICAL CENTER Partners Human Research Protection Program (HRPP) Plan 1.0 THE HRPP The HRPP of Partners HealthCare System, Inc. (Partners) is the integrated program with overall responsibility for the protection of the rights and welfare of human subjects in research for The Brigham and Women’s Hospital, Inc. (BWH), Faulkner Hospital, Inc. (FH), The General Hospital Corporation (also known as Massachusetts General Hospital) (MGH), The McLean Hospital Corporation (McLean), and North Shore Medical Center, Inc. (NSMC). In aggregate these are the Partners HRPP-covered entities. The HRPP includes specific review and oversight of research activities involving human subjects as conducted by these institutions’ institutional review boards (collectively, the Partners IRB(s) or the IRB); management of funding negotiations with government and private sponsors as conducted by the Partners Research Management Office and the Partners Clinical Research Office; provision and development of training and policies for researchers; coordination of interactions with potential as well as enrolled human subjects; conduct of quality improvement and assurance activities; and support of the compliance responsibilities of the covered institutions and investigators. 2.0 MISSION A core mission of the Partners HRPP and Partners in general, is to advance care through excellence in biomedical research. Consistent with this core mission, the HRPP’s mission is to help ensure that Partners and its hospitals protect human subjects participating in research in accordance with legal requirements and ethical guidelines. This includes research that is conducted or sponsored by the Partners HRPP-covered entities or in which the entities are otherwise engaged.
    [Show full text]
  • Mclean Hospital – Application Form and Attachments
    MASS GENERAL BRIGHAM INCORPORATED DON APPLICATION # MGB-20101916-TS TRANSFER OF SITE THE McLEAN HOSPITAL CORPORATION October 20, 2020 BY MASS GENERAL BRIGHAM INCORPORATED 800 BOYLSTON STREET, SUITE 1150 BOSTON, MA 02199 755891.1 MASS GENERAL BRIGHAM INCORPORATED DON APPLICATION # MGB-20101916-TS TABLE OF CONTENTS 1. DoN Application Form 2. DoN Transfer of Site Narrative 3. Articles of Organization 4. Affidavit of Truthfulness and Compliance 755891.1 ATTACHMENT 1 DoN APPLICATION FORM Massachusetts Department of Public Health Version: 11-8-17 Determination of Need Application Form Application Type: Transfer of Site/Change in Designated Location Application Date: 10/19/2020 4:49 pm Applicant Name: Mass General Brigham Incorporated Mailing Address: 800 Boylston Street, Suite 1150 City: Boston State: Massachusetts Zip Code: 02199 Contact Person: Andrew S. Levine Title: Attorney Mailing Address: One Beacon Street, Suite 1320 City: Boston State: Massachusetts Zip Code: 02108 Phone: 6175986700 Ext: E-mail: [email protected] Facility Information List each facility affected and or included in Proposed Project 1 Facility Name: McLean Hospital Facility Address: 115 Mill Street City: Belmont State: Massachusetts Zip Code: 02478 Facility type: Hospital CMS Number: 224007 Add additional Facility Delete this Facility 2 Facility Name: McLean Southeast Facility Address: 23 Isaac Street City: Middleborough State: Massachusetts Zip Code: 02346 Facility type: Hospital CMS Number: 224007 Add additional Facility Delete this Facility 1. About the Applicant
    [Show full text]
  • Partners Healthcare Patient Financial Counselor Contact Information
    Partners HealthCare Patient Financial Counselor Contact Information Brigham and Women’s Hospital (BWH)/Brigham and Women’s Physicians Organization (BWPO) Patient Financial Services Brigham and Women’s Hospital 45 Francis Street, ASB II – 2nd floor Main Campus Boston, MA 02115 (617) 732-7005, (866) 736-1510 Patient Financial Services Brigham and Women’s Hospital 850 Boylston Street, Suite 204B Ambulatory Care Center Boston, MA 02115 (617) 732-9677 Patient Financial Services 3297 Washington Street Brookside Community Health Center Jamaica Plain, MA 02130 (617) 522-4700 Patient Financial Services Southern Jamaica Plain Health Center 640 Centre St, Jamaica Plain, MA 02130 (617) 983-4100 Patient Financial Services Brigham and Women’s/ 22 Patriot Place, FXB II, 3rd Floor Mass General Health Care Center Foxborough, MA 02035 (508) 718-4196 Brigham and Women’s Faulkner Hospital Patient Financial Services Brigham and Women’s 1153 Centre Street, Suite 1106 Faulkner Hospital Boston, MA 02130 (617) 983- 7218 Cooley Dickinson Hospital Patient Financial Counseling Cooley Dickinson Hospital 30 Locust Street Northampton, MA 01061 (413) 582-2848 Page 1 Partners HealthCare Patient Financial Counselor Contact Information Martha’s Vineyard Hospital Patient Financial Counseling One Hospital Road Martha's Vineyard Hospital Oak Bluffs, MA 02557 (508) 957-9588 Massachusetts Eye and Ear Patient Financial Services Massachusetts Eye and Ear 243 Charles Street, 9th Floor Main Campus Boston, MA 02114 (617) 573-5664 Patient Financial Services Massachusetts Eye and
    [Show full text]
  • Partners Healthcare Hospital Credit & Collection Policy January 1, 2020
    Partners HealthCare Hospital Credit & Collection Policy January 1, 2020 PURPOSE: ................................................................... ERROR! BOOKMARK NOT DEFINED. DEFINITIONS: ............................................................. ERROR! BOOKMARK NOT DEFINED. POLICY STATEMENT: .............................................. ERROR! BOOKMARK NOT DEFINED. 1. SCOPE................................................................................................................................... 3 2. GOVERNANCE ISSUES .................................................................................................... 3 3. STATEMENT OF PRINCIPLE ........................................................................................... 3 4. CLASSIFICATION & ACCESS TO CARE ...................................................................... 4 A. GENERAL PRINCIPLE ........................................................................................................... 4 B. EMERGENT AND URGENT SERVICES .................................................................................. 4 C. NON-EMERGENT, NON-URGENT SERVICES ....................................................................... 5 D. LOCATIONS THAT PATIENTS MAY PRESENT FOR SERVICES............................................... 5 5. ACQUISITION AND VERIFICATION OF PATIENT INFORMATION ......................... 5 A. EMERGENT AND URGENT SERVICES .................................................................................. 6 B. NON-EMERGENT, NON-URGENT SERVICES
    [Show full text]
  • The World's Most Active Hospital & Healthcare
    The USA's Most Active Hospital & Healthcare Professionals on Social - August 2021 Industry at a glance: Why should you care? So, where does your company rank? Position Company Name LinkedIn URL Location Employees on LinkedIn No. Employees Shared (Last 30 Days) % Shared (Last 30 Days) 1 symplr https://www.linkedin.com/company/symplr/United States 1,101 204 18.53% 2 Covenant Care https://www.linkedin.com/company/covenant-care-corp/United States 509 88 17.29% 3 Johnson & Johnson Consumer Health https://www.linkedin.com/company/johnson-johnson-consumer-health/United States 727 112 15.41% 4 Phreesia https://www.linkedin.com/company/phreesia/United States 1,201 185 15.40% 5 Labcorp Drug Development https://www.linkedin.com/company/labcorpdrugdev/United States 4,362 661 15.15% 6 BrightSpring Health Services https://www.linkedin.com/company/brightspringhealth/United States 17,110 2,500 14.61% 7 Teladoc Health https://www.linkedin.com/company/teladoc-health/United States 3,932 572 14.55% 8 Alto Pharmacy https://www.linkedin.com/company/altopharmacy/United States 749 104 13.89% 9 Quantum Health https://www.linkedin.com/company/quantum-health/United States 899 119 13.24% 10 Imprivata https://www.linkedin.com/company/imprivata/United States 612 78 12.75% 11 American College of Cardiology https://www.linkedin.com/company/american-college-of-cardiology/United States 771 97 12.58% 12 VillageMD https://www.linkedin.com/company/villagemd/United States 862 108 12.53% 13 Oak Street Health https://www.linkedin.com/company/oak-street-health/United States 1,692 211 12.47% 14 ECRI https://www.linkedin.com/company/ecri-org/United States 539 64 11.87% 15 Shields Health Solutions https://www.linkedin.com/company/shields-health-solutions/United States 603 70 11.61% 16 Amwell https://www.linkedin.com/company/amwellcorp/United States 1,104 125 11.32% 17 St.
    [Show full text]
  • Check-Up on DE&I
    Mass General Brigham Check-up on DE&I Check-up on DE&I Dedication “When I was a boy and I would see scary things in the news, my mother would say to me, ‘Look for the helpers. You will always find people who are helping.’”― Fred Rogers This Check-up on DE&I Report is dedicated to our colleagues, “The Helpers,” who have been battling the COVID-19 pandemic this year. Their selflessness and spirit of collaboration provide steady guidance in this unprecedented time. During this pandemic, we have seen the power of Mass General Brigham as we function as an integrated system. We are thankful for our colleagues’ bravery and leadership as they combat the spread of COVID-19 in our communities and neighborhoods. Our hospital colleagues have risen above fear, xenophobia, and personal safety concerns to provide care, comfort, and aid to the patients and families we serve. Even with uncertainties about the future impact of the virus, our colleagues have remained hopeful and proactive while combatting this pandemic. We have all witnessed countless acts of kindness and generosity from so many helpers in our system. That compassion and care also extend beyond the walls of our institutions. Mass General Brigham has also provided clinical guidance and public health assistance across the Commonwealth, New England, the nation and around the globe. As COVID-19 has impacted our communities, the need to support disenfranchised and marginalized patients is critical. Health equity is more important than ever. As a system, we can collectively be helpers. We can assist and influence structures, policies, and procedures that can counter health disparities long after we have defeated COVID-19.
    [Show full text]
  • Human Research Protection Program Plan
    HUMAN RESEARCH PROTECTION PROGRAM (HRPP) 1.0 THE HRPP The Mass General Brigham HRPP is an integrated program with overall responsibility for the protection of the rights and welfare of human subjects in research for Mass General Brigham. The entities covered under the Mass General Brigham HRPP (HRPP Covered Entities) include: • The Brigham and Women’s Hospital, Inc. (BWH) • Brigham and Women’s Faulkner Hospital, Inc. (BWH/F) • The General Hospital Corporation doing business as Massachusetts General Hospital (MGH) • The MGH Institute of Health Professions, Inc. (MGH IHP) • The McLean Hospital Corporation (McLean) • Newton-Wellesley Hospital (NWH) • North Shore Medical Center, Inc. (NSMC) • Massachusetts Eye and Ear Infirmary (MEE) • Partners Private Care, LLC (PPC) • Partners Home Care, Inc. (PHC) • The Schepens Eye Research Institute, Inc. (SERI) • The Spaulding Rehabilitation Hospital Corporation (SRH) • Spaulding Hospital - Cambridge, Inc. doing business as Spaulding Hospital for Continuing Medical Care Cambridge (Spaulding Cambridge) • Spaulding Hospital of the Cape and Islands Corporation (Spaulding Cape Cod) The HRPP includes specific review and oversight of research activities involving human subjects as conducted by the Mass General Brigham Institutional Review Boards (Mass General Brigham IRB); management of funding negotiations with government and private sponsors as conducted by the Mass General Brigham Research Management Office, the Mass General Brigham Clinical Research Office, and Mass General Brigham Innovations; provision and development of training and policies for researchers; coordination of interactions with potential as well as enrolled human subjects; conduct of quality improvement and assurance activities; and support of the compliance responsibilities of the covered institutions and investigators. Mass General Brigham Human Research Protection Program Page 1 of 19 Version: 12.1.2020 2.0 MISSION A core mission of the Mass General Brigham HRPP and Mass General Brigham in general, is to advance care through excellence in biomedical research.
    [Show full text]
  • Mass General Brigham Incorporated and Affiliates Consolidated Financial Statements (With Consolidating Financial Information) September 30, 2020 and 2019
    Mass General Brigham Incorporated and Affiliates Consolidated Financial Statements (With Consolidating Financial Information) September 30, 2020 and 2019 Mass General Brigham Incorporated and Affiliates Index September 30, 2020 and 2019 Page(s) Report of Independent Auditors ........................................................................................................... 1–2 Consolidated Financial Statements Balance Sheets ............................................................................................................................................ 3 Statements of Operations ............................................................................................................................ 4 Statements of Changes in Net Assets ......................................................................................................... 5 Statements of Cash Flows ........................................................................................................................... 6 Notes to Financial Statements ............................................................................................................... 7–49 Other Financial Information Report of Independent Auditors ............................................................................................................. 50 Consolidating Balance Sheets ............................................................................................................. 51–52 Consolidating Statements of Operations ............................................................................................
    [Show full text]
  • Signed, Dan Schwarz, MD MPH, Brigham and Women's Hospital C
    Signed, Dan Schwarz, MD MPH, Brigham and Women's Hospital C. Lee, Cohen, MD MBA, Brigham and Women’s Hospital Elizabeth Donnelly, MD, Beth Israel Deaconess Medical Center Peggy Lai, MD MPH, Massachusetts General Hospital/Harvard Medical School Zeinabou Niame Daffe, Mass General Hospital Peter Olds, MD MPH, Massachusetts General Hospital, Harvard Medical School Rod Rahimi, MD, PhD, Massachusetts General Hospital, Harvard Medical School Mwanasha Hamuza Merrill, MD, Beth Israel Deaconess Medical Center Mark C Poznansky, MD, PhD, Massachusetts General Hospital, Harvard Medical School Ali Abdallah, BDS, Boston University Goldman School of Dental Medicine Yodeline Guillaume, MA, Mass General Hospital Kara Bischoff, MD, UCSF Gustavo E. Velasquez, MD, MPH, Brigham and Women's Hospital, Harvard Medical School Inobert Pierre, Health Equity International Roger Shapiro, MD, MPH, Harvard TH Chan School of Public Health Marcia B. Goldberg, MD, Massachusetts General Hospital & Harvard Medical School Harvey Simon, Mass General Hospital Asha Clarke, MD, Brigham and Women’s Hospital, Harvard Medical School Jing Ren, MD, Massachusetts General Hospital/Harvard Medical School Susan, McGirr, MD, Beth Israel Deaconess Medical Center Kristen Giambusso, MPH, Massachusetts General Hospital Shahin Lockman, MD MSc, Brigham and Women's Hospital, HSPH Jocelyne Jezzini, BDS, CAGS Jessica Haberer, MD, Massachusetts General Hospital Zahir Kanjee, MD, MPH, Beth Israel Deaconess Medical Center, Harvard Medical School Nicky Joseph, MD, Candidate Harvard Medical School Ari Johnson, MD, University of California San Francisco | Muso Sriram Shamasunder, MD DTM&H, UCSF HEAL Initiative Vijai Bhola, Beth Israel Deaconess Medical center Andrew R. Lai, MD, MPH, University of California, San Francisco Caitlin Dugdale, MD, Massachusetts General Hospital Bradley Monash, MD, UCSF Sujatha Sankaran, MD , University of California San Francisco Ana Pacheco-Navarro, MD, Stanford University Hospital Madhavi Dandu, MD MPH, UCSF Megha Shankar, MD, Stanford University Sandra J.
    [Show full text]
  • Mass General Brigham Incorporated – Multisite - 21012113-AS Date: Wednesday, April 14, 2021 2:06:00 PM
    From: A To: DPH-DL - DoN Program Subject: DoN – Mass General Brigham Incorporated – Multisite - 21012113-AS Date: Wednesday, April 14, 2021 2:06:00 PM CAUTION: This email originated from a sender outside of the Commonwealth of Massachusetts mail system. Do not click on links or open attachments unless you recognize the sender and know the content is safe. As a local resident, I support Mass General Brigham’s project to provide the same healthcare I receive today in Boston closer to my home. We need more access to care in our community – especially behavioral health, which this site will provide. I also write on behalf of acquaintances and clients who don't have the resources to drive into Boston or take public transportation. Boston may seem close to Woburn, Westwood, and Westborough, but only if you have a car. The project will also provide much needed jobs, including 300 union construction jobs and 200 permanent jobs, that will help our local economy emerge from the pandemic. I support the Mass General Brigham project and ask the Department of Public Health to approve this application. A [email protected] West Newton From: Brenda To: DPH-DL - DoN Program Subject: DoN – Mass General Brigham Incorporated – Multisite - 21012113-AS Date: Monday, April 12, 2021 10:06:52 AM CAUTION: This email originated from a sender outside of the Commonwealth of Massachusetts mail system. Do not click on links or open attachments unless you recognize the sender and know the content is safe. As a local resident, I support Mass General Brigham’s project to provide the same healthcare I receive today in Boston closer to my home.
    [Show full text]
  • Partners Ambulatory Care – Westborough Service Area Community Health Needs Assessment
    Mass General Brigham Partners Ambulatory Care – Westborough Service Area Community Health Needs Assessment October 3, 2020 TABLE OF CONTENTS EXECUTIVE SUMMARY ................................................................................................................................... i INTRODUCTION ............................................................................................................................................. 1 Purpose and Scope of the Community Health Needs Assessment ........................................................... 2 CONTEXT FOR THE COMMUNITY HEALTH NEEDS ASSESSMENT .................................................................. 3 COVID-19 Pandemic .................................................................................................................................. 3 National Movement for Racial Justice ....................................................................................................... 3 METHODS ...................................................................................................................................................... 3 Social Determinants of Health Framework ............................................................................................... 3 Upstream Approaches to Health ........................................................................................................... 4 Health Equity Lens ................................................................................................................................
    [Show full text]